Search research articles
Contact Us
Filters
Showing results (161-170 of 599) with videos related to
Page
of 60
Sort By:
Human Gene Therapy
|
March 1, 1997
Pulmonary surfactant inhibits cationic liposome-mediated gene delivery to respiratory epithelial cells in vitro
J E Duncan, J A Whitsett, A D Horowitz
British Journal of Clinical Pharmacology
|
July 1, 1995
Postextrasystolic potentiation in patients with ischaemic heart disease: influence of inotropic agents
Y I Zhang, R H Ritchie, J D Horowitz
The Medical Journal of Australia
|
February 28, 1976
A double-blind trial of perhexiline maleate in the prophylaxis of angina pectoris
M J Brown, J D Horowitz, M L Mashford
Journal of Chromatography
|
May 8, 1992
High-performance liquid chromatographic determination of sotalol in plasma. I. Application to the disposition of sotalol enantiomers in humans
B C Sallustio, R G Morris, J D Horowitz
The American Journal of Cardiology
|
October 26, 2001
Persistence of the coronary slow flow phenomenon
J F Beltrame, S P Turner, J D Horowitz
Medical Education
|
February 14, 2004
Board certification and physician quality
Sheldon D Horowitz, Stephen H Miller, Paul V Miles
Clinical and Experimental Pharmacology & Physiology
|
July 20, 2005
Lack of inotropic effect of nitric oxide on the rat myocardium
Matthew I Worthley, John D Horowitz, Christopher J Zeitz
The American Journal of Cardiology
|
July 15, 1997
Nitroglycerin tolerance at the platelet level in patients with angina pectoris
Y Y Chirkov, L P Chirkova, J D Horowitz
Medgenmed : Medscape General Medicine
|
March 4, 2008
Medical tourism: globalization of the healthcare marketplace
Michael D Horowitz, Jeffrey A Rosensweig, Christopher A Jones
Expert Opinion on Emerging Drugs
|
October 1, 2016
Emerging drugs for the treatment of angina pectoris
Cher-Rin Chong, Gao J Ong, John D Horowitz
Page
of 60
Search research articles
Search
Showing results (161-170 of 599) with videos related to
Sort By:
Page
of 60
Human Gene Therapy
|
March 1, 1997
Pulmonary surfactant inhibits cationic liposome-mediated gene delivery to respiratory epithelial cells in vitro
J E Duncan, J A Whitsett, A D Horowitz
British Journal of Clinical Pharmacology
|
July 1, 1995
Postextrasystolic potentiation in patients with ischaemic heart disease: influence of inotropic agents
Y I Zhang, R H Ritchie, J D Horowitz
The Medical Journal of Australia
|
February 28, 1976
A double-blind trial of perhexiline maleate in the prophylaxis of angina pectoris
M J Brown, J D Horowitz, M L Mashford
Journal of Chromatography
|
May 8, 1992
High-performance liquid chromatographic determination of sotalol in plasma. I. Application to the disposition of sotalol enantiomers in humans
B C Sallustio, R G Morris, J D Horowitz
The American Journal of Cardiology
|
October 26, 2001
Persistence of the coronary slow flow phenomenon
J F Beltrame, S P Turner, J D Horowitz
Medical Education
|
February 14, 2004
Board certification and physician quality
Sheldon D Horowitz, Stephen H Miller, Paul V Miles
Clinical and Experimental Pharmacology & Physiology
|
July 20, 2005
Lack of inotropic effect of nitric oxide on the rat myocardium
Matthew I Worthley, John D Horowitz, Christopher J Zeitz
The American Journal of Cardiology
|
July 15, 1997
Nitroglycerin tolerance at the platelet level in patients with angina pectoris
Y Y Chirkov, L P Chirkova, J D Horowitz
Medgenmed : Medscape General Medicine
|
March 4, 2008
Medical tourism: globalization of the healthcare marketplace
Michael D Horowitz, Jeffrey A Rosensweig, Christopher A Jones
Expert Opinion on Emerging Drugs
|
October 1, 2016
Emerging drugs for the treatment of angina pectoris
Cher-Rin Chong, Gao J Ong, John D Horowitz
Page
of 60